Safety and efficacy of intra-arterial bone marrow mononuclear cell transplantation in patients with acute ischaemic stroke in Spain (IBIS trial): a phase 2, randomised, open-label, standard-of-care controlled, multicentre trial

[1]  Yucong Peng,et al.  Potential Mechanisms and Perspectives in Ischemic Stroke Treatment Using Stem Cell Therapies , 2021, Frontiers in Cell and Developmental Biology.

[2]  Francesca N. Delling,et al.  Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association. , 2021, Circulation.

[3]  S. Kuroda,et al.  Clinical Trials of Stem Cell Therapy for Cerebral Ischemic Stroke , 2020, International journal of molecular sciences.

[4]  S. Gul,et al.  Bone Marrow Mononuclear Cells Activate Angiogenesis via Gap Junction–Mediated Cell-Cell Interaction , 2020, Stroke.

[5]  N. Tajiri,et al.  Translating intracarotid artery transplantation of bone marrow‐derived NCS‐01 cells for ischemic stroke: Behavioral and histological readouts and mechanistic insights into stem cell therapy , 2019, Stem cells translational medicine.

[6]  C. Graffagnino,et al.  A Phase 2 Randomized, Sham-Controlled Trial of Internal Carotid Artery Infusion of Autologous Bone Marrow–Derived ALD-401 Cells in Patients With Recent Stable Ischemic Stroke (RECOVER-Stroke) , 2019, Circulation.

[7]  N. Khandelwal,et al.  Randomized Assessment of the Safety and Efficacy of Intra-Arterial Infusion of Autologous Stem Cells in Subacute Ischemic Stroke , 2018, American Journal of Neuroradiology.

[8]  W. Powers,et al.  2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2018, Stroke.

[9]  A. Auchus,et al.  Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial , 2017, The Lancet Neurology.

[10]  A. McConnachie,et al.  Human neural stem cells in patients with chronic ischaemic stroke (PISCES): a phase 1, first-in-man study , 2016, The Lancet.

[11]  P. Liu,et al.  Effect of stem cell-based therapy for ischemic stroke treatment: A meta-analysis , 2016, Clinical Neurology and Neurosurgery.

[12]  S. Savitz,et al.  Systematic Review and Meta-Analysis of Bone Marrow–Derived Mononuclear Cells in Animal Models of Ischemic Stroke , 2016, Stroke.

[13]  J. Montaner,et al.  Intra-Arterial Bone Marrow Mononuclear Cells (BM-MNCS) Transplantation in Acute Ischemic Stroke (IBiS Trial): Protocol of a Phase II, Randomized, Dose-Finding, Controlled Multicenter Trial , 2015, International journal of stroke : official journal of the International Stroke Society.

[14]  N. Khandelwal,et al.  Intravenous Autologous Bone Marrow Mononuclear Stem Cell Therapy for Ischemic Stroke: A Multicentric, Randomized Trial , 2014, Stroke.

[15]  H. Yim,et al.  Efficacy and Safety of Stem Cell Therapies for Patients with Stroke: a Systematic Review and Single Arm Meta-Analysis , 2014, International journal of stem cells.

[16]  M. Hamady,et al.  Intra‐Arterial Immunoselected CD34+ Stem Cells for Acute Ischemic Stroke , 2014, Stem cells translational medicine.

[17]  Q. Zhuge,et al.  Timing and Dose Regimens of Marrow Mesenchymal Stem Cell Transplantation Affect the Outcomes and Neuroinflammatory Response After Ischemic Stroke , 2014, CNS neuroscience & therapeutics.

[18]  Steven C Cramer,et al.  Stem cells as an emerging paradigm in stroke 3: enhancing the development of clinical trials. , 2014, Stroke.

[19]  J. Aronowski,et al.  Intra-Arterial Delivery Is Not Superior to Intravenous Delivery of Autologous Bone Marrow Mononuclear Cells in Acute Ischemic Stroke , 2013, Stroke.

[20]  J. Montaner,et al.  Intra-Arterial Bone Marrow Mononuclear Cells in Ischemic Stroke: A Pilot Clinical Trial , 2012, Stroke.

[21]  D. Howells,et al.  Stem Cell-Based Therapy for Experimental Stroke: A Systematic Review and Meta-Analysis , 2012, International journal of stroke : official journal of the International Stroke Society.

[22]  J. Grotta,et al.  Intravenous autologous bone marrow mononuclear cells for ischemic stroke , 2011, Annals of neurology.

[23]  Roger Strong,et al.  Therapeutic time window and dose response of autologous bone marrow mononuclear cells for ischemic stroke , 2011, Journal of neuroscience research.

[24]  Marta P Pereira,et al.  Human neural stem cells enhance structural plasticity and axonal transport in the ischaemic brain , 2011, Brain : a journal of neurology.

[25]  K. Houkin,et al.  Therapeutic time window of mesenchymal stem cells derived from bone marrow after cerebral ischemia , 2010, Brain Research.

[26]  M. Chopp,et al.  Effects of Administration Route on Migration and Distribution of Neural Progenitor Cells Transplanted into Rats with Focal Cerebral Ischemia, an MRI Study , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[27]  Roger Strong,et al.  Autologous Bone Marrow Mononuclear Cells Enhance Recovery after Acute Ischemic Stroke in Young and Middle-Aged Rats , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[28]  M. Chopp,et al.  Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic , 2009, The Lancet Neurology.

[29]  Radovan Borojevic,et al.  Assessment of Intra-arterial Injected Autologous Bone Marrow Mononuclear Cell Distribution by Radioactive Labeling in Acute Ischemic Stroke , 2007, Clinical nuclear medicine.

[30]  R. Nogueira,et al.  Intra-Arterial Infusion of Autologous Bone Marrow Mononuclear Cells in Patients with Moderate to Severe Middle Cerebral Artery Acute Ischemic Stroke , 2012, Cell transplantation.

[31]  B. Gutfilen,et al.  Safety of autologous bone marrow mononuclear cell transplantation in patients with nonacute ischemic stroke. , 2011, Regenerative medicine.